Genetic Technologies Ltd representing 150 ordinary shares (GENE): Price and Financial Metrics
Genetic Technologies Ltd representing 150 ordinary shares (GENE)
Today's Latest Price: $4.32 USD
0.10 (2.37%)
Updated Jan 22 1:10pm
Add GENE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 55 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
GENE Stock Summary
- For GENE, its debt to operating expenses ratio is greater than that reported by only 0.37% of US equities we're observing.
- GENE's price/sales ratio is 46,030.54; that's higher than the P/S ratio of 100% of US stocks.
- Revenue growth over the past 12 months for Genetic Technologies Ltd comes in at -99.21%, a number that bests merely 0.51% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Genetic Technologies Ltd, a group of peers worth examining would be NK, ARPO, MOTS, TGTX, and CBMG.
- Visit GENE's SEC page to see the company's official filings. To visit the company's web site, go to www.gtglabs.com.
GENE Daily Price Range
GENE 52-Week Price Range
GENE Stock Price Chart More Charts
GENE Price/Volume Stats
| Current price | $4.32 | 52-week high | $6.32 |
| Prev. close | $4.22 | 52-week low | $1.56 |
| Day low | $4.24 | Volume | 199,499 |
| Day high | $4.47 | Avg. volume | 2,255,850 |
| 50-day MA | $2.42 | Dividend yield | N/A |
| 200-day MA | $2.48 | Market Cap | 19.04M |
Top Stories View All
Will Aphria’s (APHA) New European Certification Propel the Stock Higher?
Best & Worst Performing Stock Industries for January 21, 2020
Best & Worst Performing Small Cap Stocks for January 21, 2020
Best & Worst Performing Mid Cap Stocks for January 21, 2020
Best & Worst Performing Large Cap Stocks for January 21, 2020
View All Top Stories
Loading social stream, please wait...